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An Expanded Genetic Code In Mammalian Cells With A 
Functional Quadruplet Codon
Wei Niu†, Peter G. Schultz‡, and Jiantao Guo*,†
†Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, 68588, United 
States
‡Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, United States
Abstract
We have utilized in vitro evolution to identify tRNA variants with significantly enhanced activity 
for the incorporation of unnatural amino acids into proteins in response to a quadruplet codon in 
both bacterial and mammalian cells. This approach will facilitate the creation of an optimized and 
standardized system for the genetic incorporation of unnatural amino acids using quadruplet 
codons, which will allow the biosynthesis of biopolymers that contain multiple unnatural building 
blocks.
Keywords
Quadruplet codon; four-base codon; unnatural amino acids; tRNA evolution; genetic code
INTRODUCTION
The genetic code describes how information contained in nucleic acid sequence, i.e., triplet 
nucleotide codons, is translated into polypeptide sequence. Among the 64 DNA codons, 61 
encode the 20 common amino acids and 3 are generally used as stop signals with the rare 
exceptions of opal (encodes selenocysteine) and amber (encodes pyrrolysine in certain 
archaebacteria) nonsense codons. Recently, the amber codon has been used to encode 
unnatural amino acids (UAAs) in living cells using orthogonal aminoacyl-tRNA synthetase 
(aaRS)–amber suppressor tRNA (tRNACUA) pairs.1–6 Engineered archaeal tyrosyl-tRNA 
synthetase (MjTyrRS)–  and pyrrolysyl-tRNA synthetase (PylRS)–  pairs 
have enabled the incorporation of more than 60 UAAs into proteins in bacteria and higher 
organisms.1–6 To further realize the potential of this expanded genetic code, more “blank” 
codons (codons that do not encode a natural proteinogenic amino acid) are needed. To this 
end, quadruplet (frameshift) codons have been utilized to encode UAAs. The incorporation 
of UAAs in response to quadruplet codons has been achieved in cell-free systems using in 
vitro protein translation methods,7–11 in Xenopus oocytes using microinjected, chemically 
aminoacylated tRNAs,12 and in bacteria.13, 14 However, many of these approaches are 
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hampered by low UAA incorporation efficiency. Here we report a new approach to enhance 
the efficiency of quadruplet codon suppression based on engineering of the tRNA, rather 
than other components of the translational machinery. Furthermore, we show for the first 
time that the evolved tRNA can be readily utilized to incorporate UAAs into proteins in 
mammalian cells.15
RESULTS AND DISCUSSION
tRNA Library Construction and Selection
To determine whether modifications to tRNA structure can lead to improved quadruplet 
codon suppression, we chose to investigate , because its anticodon loop may not 
act as an important recognition element for its cognate PylRS16, 17 (Figure 1A). In fact, a 
recent report showed that PylRS could charge  and  as well.18 Therefore, 
mutation of the CUA anticodon to a quadruplet anticodon in  may not significantly 
affect its interaction with PylRS. In addition, previous work has shown that  is not 
recognized by endogenous aaRSs in both E. coli and mammalian cells as a result of its 
unique structural features.19, 20 This property allows us to carry out the in vitro evolution 
experiments in E. coli, and subsequently shuttle the evolved tRNAPyl directly into 
mammalian cells.
The anticodon of  was replaced with UCCU to generate , which 
recognizes the quadruplet codon AGGA. Based on the notion that mutation of the anticodon 
loop in  might modulate its binding to the ribosome, we created a tRNA library 
(Library I, theoretical diversity 256, > 99% coverage) in which four bases of the anticodon 
loop (29, 30, 34, 35) were randomized (Figure 1B). The tRNA library was subjected to a 
positive selection to identify functional  sequences in the presence of BocLysRS, 
chloramphenicol (34 μg mL−1), and a chloramphenicol acetyltransferase mutant gene 
containing the AGGA codon at a permissive site (the codon for Gln98 is replaced with 
AGGA). The survivors were further screened in the presence and absence of Nε-(tert-
butyloxycarbonyl)-L-lysine (Boc-Lys),21 and seven individual clones that only survived on 
chloramphenicol in the presence of Boc-Lys were chosen for DNA sequencing. Five of the 
sequenced clones converged on a unique sequence (referred to as M1) with the mutations 
C29A and A35C, while the other two converged to a second related sequence (referred to as 
M2) with the mutation A35U (Table 1).
We next sought to further improve the AGGA suppression efficiency by exploring mutation 
of additional structural elements in . To this end, we constructed two additional 
tRNA libraries (Library II is based on M1, theoretical diversity 6.6 × 104, > 99% coverage; 
Library III is based on M2, theoretical diversity 6.6 × 104, > 99% coverage) in which the 
sequences at positions 25–28 and 36–39 (Figure 1B) of the two hits from Library I were 
randomized. We hypothesized that sequence changes in the anticodon stem might have an 
effect on the interaction between the anticodon loop and ribosome, and therefore affect the 
efficiency of quadruplet codon suppression. Libraries II and III were subjected to the same 
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selection/screening procedure that was used for Library I, but with an increased 
concentration of chloramphenicol (50 μg mL−1). Out of the more than 103 clones that 
survived on the selection plate, 96 individual clones were replicated on selection plates with 
a range of chloramphenicol concentrations (34, 50, 75, 100, 150 μg mL−1). This experiment 
provided a qualitative comparison of the efficiency of quadruplet codon suppression by 
 mutants. Eight clones that grew with 100 or 150 μg mL−1 chloramphenicol in the 
presence of Boc-Lys but not with 34 μg mL−1 of chloramphenicol in the absence of Boc-Lys 
were chosen for sequencing. Three out of eight clones were derived from library II; two of 
them converged on a unique sequence (referred to as M4; Table 1). The other five clones 
were derived from library III; two of them converged on a unique sequence (referred to as 
M6) and another two of them converged on a second unique sequence (referred to as M7; 
Table 1). All eight clones contain the same A28G and U36C mutations (Table 1), which 
leads to the replacement of the A28-U36 with a G28-C36 base pair. No mutations were 
observed at positions 27 and 37, which leaves the G27-C37 base pair intact. The two G-C 
pairs apparently strengthen the part of the anticodon stem that is directly adjacent to the 
anticodon loop. Interestingly, all clones contain a mismatched Watson-Crick base paring at 
position 26–38 (Table 1). Based on molecular simulation with energy minimization using a 
CHARMM27 forcefield as implemented in Discovery Studio 2.5, the above mutations result 
in structural changes (Supplementary Figure 1) in the anticodon (especially the last two 
bases C and U), anticodon loop, and anticodon stem (at base pairs G26-C38, G27-C37, and 
A28-U36). Such structural changes in  may allow a favorable conformational 
adjustment of tRNA upon its binding to the A site and subsequent translocation to the P and 
E sites of the ribosome.22, 23
Characterization And Validation of Quadruplet Codon Suppression in E. coli
To further determine the efficiency and fidelity of AGGA suppression by the wild-type and 
the mutant  variants in E. coli, a frameshift mutation (AGGA) was introduced 
into GFPUV to replace the Asn149 codon (GFPUV-149AGGA). We constructed plasmid 
pLei-GFPUV-N149AGGA, which contains GFPUV-149AGGA (driven by a T5 promoter) 
and a copy of a  variant (wild-type or a mutant; expressed under the control of a 
lpp promoter). Plasmid pLei-GFPUV-N149AGGA was cotransformed into E. coli Genehog 
strain with plasmid pBK-BocLysRS, which carries a PylRS variant (Y384F mutant; from 
Methanosarcina mazei) that specifically aminoacylates  with Boc-Lys.21 Protein 
expression was carried out in LB medium supplemented with and without 5 mM Boc-Lys. 
Fluorescence analysis of E. coli cultures showed that full-length GFPUV protein was 
produced only in the presence of Boc-Lys for all  variants that were examined 
(Figure 2). This result indicates that both the wild-type and evolved  variants are 
not cross-active with any endogenous aaRSs in E. coli. All mutants (M1 and M2 from 
library I; M4 and M7 from library II and III) exhibited enhanced AGGA suppression in the 
presence of Boc-Lys relative to that of the wild-type . Two representative 
mutants (M4 and M7) from library II and III displayed the largest improvement based on the 
fluorescence assays (Figure 2).
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We further confirmed incorporation of Boc-Lys into GFPUV-149AGGA by mass 
spectrometry (Figure 3). ESI-MS analysis of the partially purified GFPUV mutant showed 
two major signals (27823.1 Da and 27954.3 Da) corresponding to GFPUV protein containing 
Boc-Lys with and without the N-terminal Met (Figure 3). The yield of the mutant GFPUV 
protein was 1 mg/L after partial purification when M7 was used. For comparison, the yield 
of GFPUV-149TAG mutant in the presence of BocLysRS and  under the same 
conditions was 4 mg/L. It was recently reported that the E. coli  could efficiently 
suppress an AGGA codon at position 134 of a sequence-optimized sfGFP variant.24 
However, we did not detect the signal (27752.1 Da) corresponding to the Arg incorporation 
in GFPUV-149AGGA (Supplementary Figure 3 and 4). Since we also did not detect obvious 
natural amino acid incorporation in response to AGGA codons in chloramphenicol 
acetyltransferase (position 98, for positive selection) and in barnase (positions 2 and 44, for 
negative assays; Supplementary Figure 5) for both wt and mutant  in our 
experiments, we hypothesized that the previous reported suppression of AGGA codon by E. 
coli  might be specific to the codon (position 134) context in sfGFP.24 In addition 
to Arg, no signals corresponding to the incorporation of other common 20 amino acids at 
position 149 were observed (Supplementary Figure 3, Supplementary Table 1), either. All 
the above observations indicate insufficient levels of natural amino acid incorporation into 
GFPUV-149AGGA and confirmed the good orthogonality of the evolved 
mutants.
An Expanded Genetic Code in Mammalian Cells With A Quadruplet Codon
Next, the activity of the evolved M7 mutant of  was examined in mammalian 
cells. AGGA suppression was monitored using an enhanced GFP (EGFP) with an AGGA 
mutation at the permissive residue 150 (EGFP-150AGGA). 293T cells were co-transfected 
with two plasmids, which contained a total of two copies of wild-type or M7 mutant 
 under the control of a human U6 promoter, and BocLysRS and 
EGFP-150AGGA genes under the control of a nonregulated CMV promoter. Following 
transfection, cells were cultured in DMEM media (containing 10% FBS and 2 mM L-
glutamine) with or without 5 mM Boc-Lys for 12 h before visualization under a 
fluorescence microscope (Figure 4). Full-length EGFP was detected only in cells 
supplemented with Boc-Lys, while no EGFP was observed otherwise. Significantly 
enhanced fluorescence was observed in cell cultures transfected with the M7 mutant (Figure 
4, Panel M7) relative to those transfected with wild-type  (Figure 4, Panel wt). 
No obvious detrimental effects on cell viability were observed for either the wild-type 
 or the M7 mutant. These results correlate well with those in E. coli, which 
indicates that the evolved  mutant is also more efficient in decoding AGGA in 
mammalian cells. Although prokaryotes have 70S ribosomes (30S small subunit, 40S large 
subunit) whereas eukaryotes have 80S ribosomes (40S small subunit, 50S large subunit), the 
interaction between ribosome and tRNA may not be that different.
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Conclusions
In summary, we have utilized an in vitro evolution approach to identify  variants 
with significantly enhanced activity for the incorporation of unnatural amino acids into 
proteins in response to a quadruplet codon. We also demonstrated that the evolved 
 variants from bacteria can be readily shuttled into a mammalian system. A 
similar approach is likely applicable to quadruplet codons other than AGGA, which will 
facilitate the creation of an optimized and standardized system for the genetic incorporation 
of unnatural amino acids using quadruplet codons. Generation of additional blank codons 
will allow the biosynthesis of biopolymers that contain more unnatural elements, which will 
further facilitate the study and manipulation of biological processes.
METHODS
Materials and General Methods
Boc-Lys was purchased from Bachem. Restriction enzymes, Antarctic phosphatase (AP) and 
T4 DNA ligase were purchased from New England Biolabs. KOD hot start DNA 
polymerase was purchased from EMD Millipore. Primers were ordered from Eurofins 
MWG Operon. Protein mass spectrometric data was collected on a Waters Synapt® G2 
mass spectrometry. Data was processed using Masslynx™ software (Waters). Standard 
molecular biology techniques25 were used throughout. Site-directed mutagenesis was carried 
out using the QuikChange™ II site-directed mutagenesis kit (Agilent Technologies) by 
following the manufacturer’s protocol. E. coli DH5α and Genehog were used for routine 
cloning and DNA propagation. All solutions were prepared in deionized water further 
treated by Barnstead Nanopure® ultrapure water purification system (Thermo Fisher 
Scientific Inc). Antibiotics were added where appropriate to following final concentrations: 
ampicillin, 100 mg L−1; kanamycin, 50 mg L−1; tetracycline, 12.5 mg L−1.
Plasmid construction
Plasmid pLei-GFPUV-N149AGGA was obtained by first introducing the AGGA mutation 
into plasmid pLei-GFPUV-N149TAG26 by site-directed mutagenesis using following 
primers, 5′-GAGTACAACTATAACTCACACAGGAGTATACATCACGGCAGACAA-3′ 
and 5′-TTGTCTGCCGTGA-TGTATACTCCTGTGTGAGTTATAGTTGTACTC-3′. The 
original tRNA on pLei- GFPUV-N149TAG was subsequently replaced with wild-type 
. Variants of pLei-GFPUV-N149AGGA were constructed by replacing the wild-
type  with evolved tRNA mutants.
Plasmid pBK-BocLysRS was constructed by inserting BocLysRS-encoding gene behind the 
constitutive glnS promoter (PglnS) on pBK vector.27
Plasmid pREP-BocLysRS-AGGA (for positive selection) was constructed by modifying 
plasmid pRepCM12b.26 Specifically, the TAG codon (position 98) in the chloramphenicol 
acetyltransferase-encoding gene on pRepCM12b was changed to AGGA by site-directed 
mutagenesis using following primers, 5′-
CGCTCTGGAGTGAATACCACAGGAGATTTCCGGCAGTTTCTACA-3′ and 5′-
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GTAGAAACTGCC-GGAAATCTCCTGTGGTATTCACTCCAGAGCG-3′. The resulting 
plasmid, pRepCM12b-AGGA, was digested with XbaI and ligated to a DNA fragment 
containing PglnS-BocLysRS cassette, which was amplified from template pBK-BocLysRS, 
to yield plasmid pREP-BocLysRS-AGGA.
Plasmid pNEG-AGGA (for negative selection) was constructed by modifying plasmid 
pNEG(−)tRNA.26 Codons of Gln2 and Asp44 of the barnase-encoding gene were changed 
to AGGA by overlapping PCR. The PCR product was digested with NdeI and EcoRI, then 
ligated into pNEG(−)tRNA that was treated with the same restriction enzymes to afford 
plasmid pNEG-AGGA. The resulting plasmid contains the p15A replication origin, the 
ampicillin resistance marker, the AraC-encoding gene, and the mutant barnase gene that was 
under the control of the arabinose promoter (pBAD). The overlapping PCR was carried out 
using the following primers: 5′-
GGAATTCCATATGGCAAGGAGTTATCAACACGTTTGACGGG- 3′, 5′-
TGCAAGGTTCCCTTTTGATGCCAC-3′, 5′-
GCATCAAAAGGGAACCTTGCAAGGAGTCGCTCCGGGGAAAAGCATC- 3′, and 5′-
AGCTTGGCACTGGCCGTCGTT-3′.
Plasmid pCMV-BocLysRS was constructed as follows: The wild-type  gene 
lacking 3′ CCA termini but with a 3′-TTTTTCT sequence was amplified and fused behind a 
human U6 promoter by overlapping PCR. The resulting gene cassette was inserted into the 
MfeI site of pcDNA3.1/hygro(+, Life Technologies) to yield plasmid pcDNA3.1- 
. The BocLysRS-encoding gene was PCR amplified and inserted behind a non-
regulated CMV promoter on pcDNA3.1-  to afford plasmid pCMV-BocLysRS. 
Variants of the pCMV-BocLysRS plasmid were constructed by replacing the wild-type 
 with evolved tRNA mutants.
Plasmid pEGFP-150AGGA was constructed similarly as for pCMV-BocLysRS. The EGFP- 
150AGGA gene was generated using overlapping PCR to replace the codon of Asn150 with 
AGGA. The resulting gene was inserted behind the non-regulated CMV promoter on 
pcDNA3.1-  to afford plasmid pEGFP-150AGGA. Variants of the 
pEGFP-150AGGA plasmid were constructed by replacing the wild-type  with 
evolved tRNA mutants.
tRNA library construction
Procedures for library construction were adapted from Noren and Noren.28 Mutants of 
tRNA were obtained by overlapping PCR using pBK-mmPylT as the template.29 Resulting 
PCR products contains DNA cassettes of lpp promoter-tRNA mutant-rrnC terminator. 
Digestion of PCR products with NcoI and XhoI followed by ligation between NcoI and XhoI 
sites of pBK vector resulted in the tRNA library. The primers that were used for library 
construction can be found in supporting information.
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Positive selection
Library DNAs were transformed into DH10B electrocompetent cells containing plasmid 
pREP-BocLysRS-AGGA. Transformants were cultivated in LB media containing 
kanamycin and tetracycline. After 12 h of cultivation, cells were harvested. Based on 
calculation, a certain number of cells (> 4.6 × the size of the library) were plated on LB agar 
containing kanamycin, tetracycline, Boc-Lys (5 mM), and chloramphenicol (34 mg L−1 for 
library I, 50 mg L−1 for library II and III). The selection plates were incubated at 37 °C for 
48–72 h. Selected numbers of single colonies were further screened by replication onto 
plates with certain concentrations of chloramphenicol in the presence and absence of Boc-
Lys. Only the ones that grew in the presence of Boc-Lys and did not grew in the absence of 
Boc-Lys were selected for further evaluation.
Negative selection assay
E. coli Genehog was co-transformed with plasmids pNEG-AGGA and pBK-tRNA (a 
plasmid contains  variant of interest, see library construction), and plated on solid 
LB media containing ampicillin (to maintain the pNEG-AGGA plasmid), kanamycin (to 
maintain the pBK-tRNA plasmid), and 0% or 0.2% L-arabinose (w/v; to activate the 
transcription of mutant barnase gene). The cell growth was checked after 12 h of incubation 
at 37 °C. If the  variant of interest is charged by endogenous aaRSs or if the 
AGGA codon is suppressed by endogenously charged tRNAs, cells should die due to the 
expression of full-length toxic barnase protein. Normal cell growth should be observed if the 
 variant of interest is not charged by endogenous aaRSs and if the AGGA codon 
is not suppressed by any endogenously charged tRNAs (See Supplementary Figure 5 for 
results).
Fluorescence analysis of bacterial culture
E. coli Genehog strain harboring plasmid pBK-BocLysRS and a pLei-GFPUV-N149AGGA 
variant was cultured in 5 mL LB media containing kanamycin and chloramphenicol at 37 
°C. The protein expression was induced at the OD600nm of 0.6 by additions of IPTG (0.5 
mM) and Boc-Lys (5 mM). Following cultivation at 37 °C for an additional 16 h, 1 mL of 
cell culture were collected, washed, then resuspended in 1 mL of potassium phosphate 
buffer (50 mM, pH 7.4). The processed cells were directly used for fluorescence and cell 
density measurements using a Synergy™ H1 Hybrid plate reader (BioTek Instruments). The 
fluorescence of GFPUV was monitored at λEx = 390 nm and λEm = 510 nm. The cell density 
was estimated by measuring the sample absorbance at 600 nm. Values of fluorescence 
intensity were normalized to cell growth. Reported data are the average of three 
measurements with standard deviations.
Protein expression in bacteria
Similar cell cultivation procedure for fluorescence analysis of bacterial culture was applied 
to E. coli strains that were used for protein purification. The only modification is that 100 
mL of culture was grown. Cells were collected by centrifugation at 5 000g and 4 °C for 15 
min. Harvested cells were resuspended in lysis buffer containing potassium phosphate (20 
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mM, pH 7.4), NaCl (150 mM) and imidazole (10 mM). Cells were subsequently disrupted 
by sonication. Cellular debris was removed by centrifugation (21 000g, 30 min, 4 °C). The 
cell-free lysate was applied to Ni Sepharose 6 Fast Flow resin (GE Healthcare). Protein 
purification followed manufacture’s instructions. Protein concentrations were determined by 
Bradford assay (Bio-Rad). Purified protein was desalted prior to MS analysis.
Protein expression in 293T cells
293T cells were grown in media containing DMEM, 10% FBS (v/v), and 2 mM L-glutamine 
at 37 °C in a humidified atmosphere of 5% CO2 (v/v). When cells reached 60–70% 
confluency, cell culture media was exchanged to fresh DMEM media (containing 10% FBS 
and 2 mM L-glutamine) with or without 5 mM Boc-Lys and the cells were grown for an 
additional 30 minutes before transfection. Cells were transfected with plasmids pCMV-
BocLysRS and pEGFP-150AGGA variants using Lipofectamine™ 2000 (Life Technologies) 
according to the manufacturer’s protocol (8 μL Lipofectamine + 2 μg of pCMV-BocLysRS 
+ 2 μg of pEGFP-150AGGA for 2 mL cell culture in Costar 6- well cell-culture clusters). 
Cells were grown for an additional 12 h before being washed with DMEM base medium, 
fixed with 4% paraformaldehyde (w/v), washed three times with DPBS, and visualized by 
an Inverted (Olympus IX 81) confocal microscope.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
The structure of . (A) Crystal structure of PylRS-  from 
Desulfitobacterium hafniense (PDB, 2ZNI; The co-crystal structure lacks the N-terminal 
part of the PylRS);16 (B) Clover leaf structures of tRNAPyl from Methanosarcina barkeri. In 
bold, anticodon; underlined, nucleotides in the anticodon loop that were randomized; grey in 
bold, nucleotides in the anticodon stem that were randomized.
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Figure 2. 
GFPUV fluorescence assays of cells expressing  variants. Fluorescence readings 
of E. coli Genehog cells expressing wt  (leftmost bar) or the evolved 
mutants, each coexpressed with BocLysRS. Fluorescence intensity was normalized to cell 
growth. Each data point is the average of triplet measurements with standard deviation.
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Figure 3. 
Deconvoluted ESI-MS spectra of the GFPUV-N149-Boc-Lys mutant. Expected masses: 
27824.1 Da (without the N-terminal Met) and 27955.2 (with the N-terminal Met); observed 
masses: 27823.1 Da and 27954.3 Da. The 27723.7 Da signal may correspond to the protein 
that lost Boc group under mass spectrometry conditions. The 27766.9 Da signal does not 
correspond to GFPUV mutant that contains any of the 20 proteogenic amino acids at position 
149. Supplementary Figure 3 shows the ESI-MS spectra before deconvolution.
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Figure 4. 
Suppression of AGGA in EGFP150AGGA protein in 293T cells. The left picture in each 
panel represents fluorescence image and the right picture in each panel represents 
overlapped bright field and fluorescence images.
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